Navigation Links
Next Generation Proton Therapy System for Cancer Treatment Set for Release This Year

LITTLETON, Mass., Feb. 26 /PRNewswire/ -- Still River Systems announced today the successful operation of the world's highest field, high energy cyclotron magnet. Still River's magnet is the key technical element for reducing the size and cost of the particle accelerator that will deliver proton therapy at a number of hospitals beginning with the first installation at Barnes Jewish Hospital in St. Louis, Missouri this fall.

"The last six months have been very exciting," said Marc Buntaine, CEO. "Still River has achieved all of the component milestones that bring us to system integration and delivery." Proton therapy, widely regarded as the next evolutionary step in the radiation treatment of cancer, has seen unprecedented interest from the radiation oncology and patient communities in recent years. However, the large size and high cost of existing proton therapy systems have made it difficult for the average hospital to add this powerful tool to their cancer fighting arsenal.

The heart of the Monarch250, a superconducting magnet developed in an industrial and academic partnership with the Massachusetts Institute of Technology, has now tested operational and stable at its full design current "This magnet sets a record for magnetic field strength used in a high energy cyclotron. The cyclotron built around this magnet will be the most compact source for proton therapy available today." said Dr. Kenneth Gall, founder and Chief Technology Officer. "All of the Monarch250 sub-systems are now in the final phases of manufacturing and will be ready to ship to our first customers for installation later this year".

Still River's Monarch250 proton therapy system, a unique and compact machine, was developed to provide proton therapy at a greatly reduced cost and size. In addition, Still River Systems has incorporated the latest advancements in radiation therapy patient management with its innovative accelerator technology, including a robotic couch for patient positioning, dedicated proton therapy treatment planning, cone beam CT imaging, and motion management. All of these clinical systems have been integrated within the Monarch250 platform. "Our goal is to provide our customers with a fully integrated, turnkey proton therapy solution with the most advanced clinical systems for patient management" said Dr. Skip Rosenthal, Vice President of Clinical Systems. "Integrating these key radiation therapy technologies is critical to ease of use in a clinical setting."

Still River Systems first installation sites, Barnes Jewish Hospital in St. Louis, Missouri and Robert Wood Johnson University Hospital in New Jersey, have begun construction for the new facilities that will house the first Monarch250 systems in the United States.

Still River Systems, based in Littleton, Massachusetts, is dedicated to providing physicians and their patients' access to high quality, cost-effective proton therapy solutions. Still River Systems is developing the Monarch250, an affordable, precise and compact proton therapy system for cancer treatment. This system has not yet been cleared by the FDA for commercial use in clinical therapy. For more information on Still River Systems and the Monarch250 Proton Therapy System, please call 978-540-1500 or visit

SOURCE Still River Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
2. Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist
3. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
4. Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
5. Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma
6. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
7. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
8. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
9. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
10. Stem Cell Regeneration Repairs Congenital Heart Defect
11. TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and Markets ... "Advanced Wound Care Market by Type (Dressings, Therapy ... User (In-Patient Facility, Out-Patient Facility), and Geography - Global ... --> --> The ... definition and forecast of the global advanced wound care ...
(Date:11/26/2015)... PUNE, India , November 26, ... --> --> ... Research Report" and "Investigation Report on ... 2019 and 2021 forecasts data and ... library. . ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... changing the way that they are handling security in light of the recent terrorist ... presence in an attempt to stop an attack from reaching U.S. soil. Especially around ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap ... Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health ... both STEMI and Sepsis conditions present in similar ways and require time-critical intervention to ...
Breaking Medicine News(10 mins):